Dr. Robert Daniel Mullin Jr., DO

Dr. Mullin practices at Penn Medicine Lghp Walter L. Aument Family Health Center in Quarryville, Pennsylvania.

Dr. Mullin's NPI, 1356978183, was assigned on March 23, 2020. Dr. Mullin holds Pennsylvania license OS023514.

Dr. Mullin's primary practice is Penn Medicine Lghp Walter L. Aument Family Health Center, at 317 W Chestnut St, Quarryville, PA 17566 in Lancaster County. The practice phone is (717) 786-7383.

Dr. Mullin's primary practice is Penn Medicine Lghp Walter L. Aument Family Health Center in Quarryville, Pennsylvania. Dr. Mullin is also affiliated with Temple University Hospital. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Mullin to 1 more hospital, 4 medical groups, 3 group practices and clinics and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mullin practices, 6 sites in all. Vendor and product names are available with a free account.

Pediatrics is Dr. Mullin's primary specialty in the NPI Registry, under taxonomy code 208000000X. Dmand AI has Dr. Mullin's licenses on file in 3 states: Pennsylvania, Maryland and Ohio.

CMS data shows 12 Medicare services from Dr. Mullin across 1 procedure code in 2024, for 28 Medicare patients. Medicare paid $1,265 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 28 Medicare patients who saw Dr. Mullin in 2024. The largest group is 65 to 74, with 12 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mullin's median patient age at 26, with 54% women.

In 2024, Dr. Mullin wrote 154 Medicare Part D claims for 23 patients. 83% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $132 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Mullin for performance year 2024, reported as part of a group. Dr. Mullin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Mullin in 2023. 2023 was the busiest year, with 2. Dr. Mullin's most frequent co-author is Rosemary Claire Roden, MD.